Extracellular vesicles from human breast cancer-resistant cells promote acquired drug resistance and pro-inflammatory macrophage response
IntroductionBreast cancer is a significant public health problem around the world, ranking first in deaths due to cancer in females. The therapy to fight breast cancer involves different methods, including conventional chemotherapy. However, the acquired resistance that tumors develop during the tre...
Saved in:
| Main Authors: | Patrick Santos, Caroline P. Rezende, Renan Piraine, Bianca Oliveira, Francielle B. Ferreira, Vinicius S. Carvalho, Rodrigo T. Calado, Matteo Pellegrini, Fausto Almeida |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2024-10-01
|
| Series: | Frontiers in Immunology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2024.1468229/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
USP51/GRP78/ABCB1 axis confers chemoresistance through decreasing doxorubicin accumulation in triple-negative breast cancer cells
by: Yang Ou, et al.
Published: (2025-05-01) -
DDRGK1 Enhances Osteosarcoma Chemoresistance via Inhibiting KEAP1‐Mediated NRF2 Ubiquitination
by: Xin Wang, et al.
Published: (2023-05-01) -
Strategies to Overcome Intrinsic and Acquired Resistance to Chemoradiotherapy in Head and Neck Cancer
by: Tycho de Bakker, et al.
Published: (2024-12-01) -
Editorial: Advances in chemotherapy-resistant hepatocellular carcinoma, volume II
by: Shui Liu, et al.
Published: (2025-03-01) -
Long-Acting Extracellular Vesicle-Based Biologics in Osteoarthritis Immunotherapy
by: Philip Drohat, et al.
Published: (2025-05-01)